TY - JOUR
T1 - PTSD improvement and incident cardiovascular disease in more than 1000 veterans
AU - Scherrer, Jeffrey F.
AU - Salas, Joanne
AU - Schneider, F. David
AU - Friedman, Matthew J.
AU - van den Berk-Clark, Carissa
AU - Chard, Kathleen M.
AU - Norman, Sonya B.
AU - Lustman, Patrick J.
AU - Tuerk, Peter
AU - Schnurr, Paula P.
AU - Cohen, Beth E.
N1 - Funding Information:
National Heart, Lung and Blood Institute, PTSD Treatment: Effects on Health Behavior, Cardiovascular and Metabolic Disease, R01HL125424.
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/7
Y1 - 2020/7
N2 - Background: Posttraumatic stress disorder (PTSD) is associated with increased risk for cardiovascular disease (CVD). Whether clinically meaningful PTSD improvement is associated with lowering CVD risk is unknown. Methods: Eligible patients (n = 1079), were 30–70 years old, diagnosed with PTSD and used Veterans Health Affairs PTSD specialty clinics. Patients had a PTSD Checklist score (PCL) ≥ 50 between Fiscal Year (FY) 2008 and FY2012 and a second PCL score within 12 months and at least 8 weeks after the first PCL ≥ 50. Clinically meaningful PTSD improvement was defined by ≥20 point PCL decrease between the first and second PCL score. Patients were free of CVD diagnoses for 1 year prior to index. Index date was 12 months following the first PCL. Follow-up continued to FY2015. Cox proportional hazard models estimated the association between clinically meaningful PTSD improvement and incident CVD and incident ischemic heart disease (IHD). Sensitivity analysis stratified by age group (30–49 vs. 50–70 years) and depression. Confounding was controlled using propensity scores and inverse probability of exposure weighting. Results: Patients were 48.9 ± 10.9 years of age on average, 83.3% male, 60.1% white, and 29.5% black. After controlling for confounding, patients with vs. without PTSD improvement did not differ in CVD risk (HR = 1.08; 95%CI: 0.72–1.63). Results did not change after stratifying by age group or depression status. Results were similar for incident IHD. Conclusions: Over a 2–7 year follow-up, we did not find an association between clinically meaningful PTSD improvement and incident CVD. Additional research is needed using longer follow-up.
AB - Background: Posttraumatic stress disorder (PTSD) is associated with increased risk for cardiovascular disease (CVD). Whether clinically meaningful PTSD improvement is associated with lowering CVD risk is unknown. Methods: Eligible patients (n = 1079), were 30–70 years old, diagnosed with PTSD and used Veterans Health Affairs PTSD specialty clinics. Patients had a PTSD Checklist score (PCL) ≥ 50 between Fiscal Year (FY) 2008 and FY2012 and a second PCL score within 12 months and at least 8 weeks after the first PCL ≥ 50. Clinically meaningful PTSD improvement was defined by ≥20 point PCL decrease between the first and second PCL score. Patients were free of CVD diagnoses for 1 year prior to index. Index date was 12 months following the first PCL. Follow-up continued to FY2015. Cox proportional hazard models estimated the association between clinically meaningful PTSD improvement and incident CVD and incident ischemic heart disease (IHD). Sensitivity analysis stratified by age group (30–49 vs. 50–70 years) and depression. Confounding was controlled using propensity scores and inverse probability of exposure weighting. Results: Patients were 48.9 ± 10.9 years of age on average, 83.3% male, 60.1% white, and 29.5% black. After controlling for confounding, patients with vs. without PTSD improvement did not differ in CVD risk (HR = 1.08; 95%CI: 0.72–1.63). Results did not change after stratifying by age group or depression status. Results were similar for incident IHD. Conclusions: Over a 2–7 year follow-up, we did not find an association between clinically meaningful PTSD improvement and incident CVD. Additional research is needed using longer follow-up.
KW - Cardiovascular disease
KW - Epidemiology
KW - Posttraumatic stress disorder
KW - Psychotherapy
KW - Veterans
UR - http://www.scopus.com/inward/record.url?scp=85086481967&partnerID=8YFLogxK
U2 - 10.1016/j.jpsychores.2020.110128
DO - 10.1016/j.jpsychores.2020.110128
M3 - Article
C2 - 32403058
AN - SCOPUS:85086481967
SN - 0022-3999
VL - 134
JO - Journal of Psychosomatic Research
JF - Journal of Psychosomatic Research
M1 - 110128
ER -